Pl Gran.


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 18.9%
Nasopharyngitis 13.7%
Pharyngitis 13.0%
Product Used For Unknown Indication 7.9%
Nerve Injury 7.0%
Pyrexia 6.8%
Insomnia 4.4%
Pneumonia 3.5%
Urinary Tract Infection 3.5%
Autism 2.6%
Diabetes Mellitus 2.6%
Epilepsy 2.6%
Hypertension 2.2%
Bronchitis 2.0%
Constipation 2.0%
Schizophrenia 1.8%
Angina Pectoris 1.3%
Arthralgia 1.3%
Cardiac Valve Disease 1.3%
Upper Respiratory Tract Inflammation 1.3%
Toxic Epidermal Necrolysis 17.5%
Stevens-johnson Syndrome 15.0%
Rash Generalised 12.5%
Ulcerative Keratitis 7.5%
Pneumonia Aspiration 5.0%
Renal Failure 5.0%
Blood Lactate Dehydrogenase Increased 3.8%
Cardiac Failure Acute 3.8%
Delirium 3.8%
Multiple Drug Overdose Intentional 3.8%
Thrombotic Thrombocytopenic Purpura 3.8%
Blood Alkaline Phosphatase Increased 2.5%
Eosinophilic Pneumonia 2.5%
Flushing 2.5%
Hepatitis Fulminant 2.5%
Organising Pneumonia 2.5%
White Blood Cell Count Increased 2.5%
Angioedema 1.3%
Blood Urea Increased 1.3%
Cardio-respiratory Arrest 1.3%
Concomitant
Prophylaxis 15.6%
Nasopharyngitis 12.1%
Upper Respiratory Tract Inflammation 9.5%
Pyrexia 7.0%
Hypertension 5.5%
Insomnia 5.3%
Constipation 4.6%
Drug Use For Unknown Indication 4.2%
Lupus Nephritis 4.0%
Multiple Sclerosis 3.8%
Pharyngitis 3.5%
Renal Cell Carcinoma 3.3%
Upper Respiratory Tract Infection 3.3%
Benign Prostatic Hyperplasia 2.9%
Diabetes Mellitus 2.9%
Pain 2.9%
Rheumatoid Arthritis 2.9%
Bronchitis 2.7%
Diarrhoea 2.0%
Infection Prophylaxis 1.8%
White Blood Cell Count Decreased 12.8%
Upper Respiratory Tract Infection 8.1%
Weight Decreased 8.1%
White Blood Cell Count Increased 8.1%
Vomiting 7.0%
Interstitial Lung Disease 5.8%
Loss Of Consciousness 5.8%
Hepatic Function Abnormal 4.7%
Pleural Effusion 4.7%
Pyrexia 4.7%
Rash 4.7%
Dyspnoea 3.5%
Hyperkalaemia 3.5%
Palpitations 3.5%
Skin Exfoliation 3.5%
Blood Immunoglobulin E Increased 2.3%
Cardiac Failure Chronic 2.3%
Cellulitis 2.3%
Constipation 2.3%
Cytogenetic Abnormality 2.3%

Drug Data